HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dial brand sales grow 8.4% to $94.6 mil. in second quarter FY 1998.

This article was originally published in The Rose Sheet

Executive Summary

DIAL LIQUID SOAP SALES REBOUND 40% IN SECOND QUARTER of FY 1998 (ended June 28), following a period during which the liquid hand soap was "beaten up pretty badly by the competition," Dial Corp. CEO Malcolm Jozoff told securities analysts in a July 24 conference call. Liquid Dial lost positioning partly because its pricing was "out of line" with competitors' products, the Dial Corp. exec explained. To counter the sales decline, the company took aggressive action in the last quarter by merchandising Dial bar and liquid soap together, and "aggressively" pursuing the discount club store business, Jozoff noted. The refocusing effort paid off; Liquid Dial "replaced the competition" at Price Costco, and "took over the preferred position" in Sam's Clubs, he said.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel